Received: from DU6PEPF0000B61B.eurprd02.prod.outlook.com
 (2603:10a6:10:3b:cafe::10) by DU2PR04CA0001.outlook.office365.com
 (2603:10a6:10:3b::6) with Microsoft SMTP Server (version=TLS1_3,
 cipher=TLS_AES_256_GCM_SHA384) id 15.21.139.11 via Frontend Transport; Thu,
 18 Jun 2026 11:18:56 +0000
Received: from DU2PR04CA0001.eurprd04.prod.outlook.com (2603:10a6:10:3b::6) by
 DB3PR0202MB9058.eurprd02.prod.outlook.com (2603:10a6:10:437::18) with
 Microsoft SMTP Server (version=TLS1_2,
 cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.139.11; Thu, 18 Jun
 2026 11:18:56 +0000
Received: from mail1.rit.ee (213.184.53.4) by
 DU6PEPF0000B61B.mail.protection.outlook.com (10.167.8.132) with Microsoft
 SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.139.8
 via Frontend Transport; Thu, 18 Jun 2026 11:18:56 +0000
Received: from srvexch2.kliinikum.ee (HELO outlook.kliinikum.ee) ([192.168.20.104])
  by spamgwp8.kliinikum.ee with ESMTP/TLS/ECDHE-RSA-AES128-GCM-SHA256; 18 Jun 2026 14:18:55 +0300
Received: from srvexch2.kliinikum.ee ([192.168.20.104]) by
 srvexch2.kliinikum.ee ([192.168.20.104]) with mapi id 15.01.2375.031; Thu, 18
 Jun 2026 14:18:49 +0300
Received: from srvexch2.kliinikum.ee (192.168.20.104) by srvexch2.kliinikum.ee
 (192.168.20.104) with Microsoft SMTP Server (version=TLS1_2,
 cipher=TLS_ECDHE_RSA_WITH_AES_128_GCM_SHA256) id 15.1.2375.31; Thu, 18 Jun
 2026 14:18:55 +0300
Received: from DB3PR0202MB9058.eurprd02.prod.outlook.com
 (2603:10a6:10:437::18) by DB9PR02MB7817.eurprd02.prod.outlook.com with HTTPS;
 Thu, 18 Jun 2026 11:18:59 +0000
From: "Taavi Teder" <Taavi.Teder@kliinikum.ee>
To: "Info - SOM" <info@sm.ee>
Subject: =?iso-8859-1?Q?Tervisejuhtimise_t=F6=F6laud?=
Date: Thu, 18 Jun 2026 14:18:49 +0300
Keywords: Mall
Message-ID: <c0a3939cfbae46cb8abfb941b4639eab@kliinikum.ee>
MIME-Version: 1.0
Content-Type: text/plain;
	charset="iso-8859-1"
Content-Transfer-Encoding: 8bit
X-Mailer: Microsoft Outlook 16.0
Thread-Index: AQEgD8ORGVfuc5nUGTuiOGPdqAIZEA==
Authentication-Results: spf=fail (sender IP is 213.184.53.4)
 smtp.mailfrom=kliinikum.ee; dkim=pass (signature was verified)
 header.d=kliinikum.ee;dmarc=pass action=none
 header.from=kliinikum.ee;compauth=pass reason=100
X-CSE-ConnectionGUID: NV43DAJ2TSW/qoGGjhYSDA==
X-CSE-ConnectionGUID: RX1MchCAT3mIZZ+GdZWYvQ==
X-CSE-MsgGUID: +6AmymndTfW0QEm4kEPMbQ==
X-CSE-MsgGUID: iqDMGfDtTg2G0H+2ULAv6g==
X-ThreatScanner-Verdict: Negative
X-Talos-CUID: =?us-ascii?q?9a23=3AAMg9jWurudQChR/lWGpR1NFq6IsDTCGG4F7yeXO?=
 =?us-ascii?q?DNiFwT5K6S1+hw49Nxp8=3D?=
X-Talos-MUID: =?us-ascii?q?9a23=3AiX+wMQ2erpShl8U7S5Tn1++a0zUjoPqHDVEIl5k?=
 =?us-ascii?q?6tfbcDAF1ZzSwtBG9e9py?=
X-IronPort-AV: E=Sophos;i="6.24,211,1774303200"; 
   d="scan'208";a="72845681"
X-MS-Exchange-Organization-ExpirationStartTime: 18 Jun 2026 11:18:56.6138
 (UTC)
X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit
X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000
X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit
X-MS-Exchange-Organization-Network-Message-Id: 385b11e0-2561-46b4-f9db-08decd2b6347
X-EOPAttributedMessage: 0
X-EOPTenantAttributedMessage: 8fe098d2-428d-4bd4-9803-7195fe96f0e2:0
X-MS-Exchange-Organization-MessageDirectionality: Incoming
X-MS-PublicTrafficType: Email
X-MS-TrafficTypeDiagnostic: DU6PEPF0000B61B:EE_|DB3PR0202MB9058:EE_|DB9PR02MB7817:EE_
X-MS-Exchange-Organization-AuthSource: DU6PEPF0000B61B.eurprd02.prod.outlook.com
X-MS-Exchange-Organization-AuthAs: Anonymous
X-MS-Office365-Filtering-Correlation-Id: 385b11e0-2561-46b4-f9db-08decd2b6347
X-MS-Exchange-AtpMessageProperties: SA|SL
X-MS-Exchange-Organization-SCL: -1
X-Microsoft-Antispam: BCL:0;ARA:13230040|82310400026|55112099003|18003699003|16102099003|56012099006|5063699009|19002099009|11063799006;
X-Forefront-Antispam-Report: CIP:213.184.53.4;CTRY:EE;LANG:et;SCL:-1;SRV:;IPV:CAL;SFV:NSPM;H:mail1.rit.ee;PTR:mail1.rit.ee;CAT:NONE;SFS:(13230040)(82310400026)(55112099003)(18003699003)(16102099003)(56012099006)(5063699009)(19002099009)(11063799006);DIR:INB;
X-MS-Exchange-CrossTenant-OriginalArrivalTime: 18 Jun 2026 11:18:56.4693
 (UTC)
X-MS-Exchange-CrossTenant-Network-Message-Id: 385b11e0-2561-46b4-f9db-08decd2b6347
X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2
X-MS-Exchange-CrossTenant-AuthSource: DU6PEPF0000B61B.eurprd02.prod.outlook.com
X-MS-Exchange-CrossTenant-AuthAs: Anonymous
X-MS-Exchange-CrossTenant-FromEntityHeader: Internet
X-MS-Exchange-Transport-CrossTenantHeadersStamped: DB3PR0202MB9058
X-MS-Exchange-Transport-EndToEndLatency: 00:00:02.7257979
X-MS-Exchange-Processed-By-BccFoldering: 15.21.0139.008
X-MS-Exchange-ExternalInOutlookResult: NotEnabled
X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(4710137)(4717077)(4999163)(920097)(930201)(20251009189)(140003);
X-Microsoft-Antispam-Message-Info: =?us-ascii?Q?pyHLhGnXeXvrU58Ihe6Q+kfslplZFMkIc4Gxu/qQZeDIWW8+J1Lp0L7Q0qM1?=
 =?us-ascii?Q?Myx/v/cY3UyS2ku4V6yMIQVVK5RYA8YobVuxLps05SfG7s0Nq/k3nrqQesbp?=
 =?us-ascii?Q?aRsQIaxPQ1Calb/vYKk5u2S01d5EttxfiD+jY0iDUejHiA62F340u2n9gsP6?=
 =?us-ascii?Q?cySTFNOPHq+CdhIZefWZJMm6zxNz+JxcHy9Q2Tsmn7fhnccFP4hQ59DxNiNH?=
 =?us-ascii?Q?iZmYhirig9tirkxqgAqPDvehW44fqc1gNbTHfCFw3cHEdEZmB83nJRyhiRCZ?=
 =?us-ascii?Q?W0Be9xK5vBNIBGg5Mwd/BGM1LmNOAhzWbvLnVheycrD9sYYGVl3xWDHzikvc?=
 =?us-ascii?Q?t/6bK1ZYX90tP3hy1yl75ezsNTtzohM5L0BMzJkU/40/ptkFU8hYOuWR4aDq?=
 =?us-ascii?Q?CD/ROSxP9puTJhZ7zPaPG+hp1P/jID2sVMTwu09u7sx8S2/ECfumRWwSKhSk?=
 =?us-ascii?Q?tp6JSJjAaMz8v4sFHEwOxvj3BW0ZLcmYzobZMlCwYcBuc8utkgCiQLSFNtIW?=
 =?us-ascii?Q?/xp2FL1OI3R9Bnpd2DQUIZ5McZo2zo29zkBcm37mK0nCb7E4h+JjrpMEP7qD?=
 =?us-ascii?Q?4yW8Z2/93EMpHwH2BvRR/NSx7o3IOkD8z0B24mV5RTsnvtmgzmkUViCMIApz?=
 =?us-ascii?Q?BYE8cRWhZ5WoNTy37S8XkODBdQHCA6JW/d9S/enav2oykFG9sx7uTQ+SCE9e?=
 =?us-ascii?Q?Dl/tPP2Yn/rMyyqtMH16M+jMYxiwsIw18rI/MVHuvNasqqc6r10
	S5MIfiZ7X?=
 =?us-ascii?Q?SJbLutNdm00CnlPyH6iqqXUgEaKZjH4xv67Su58ZEATJLbCT9M06+gvziZxr?=
 =?us-ascii?Q?1QcEcs2A1fdfTW7bXta1f1Wq/zEjL+jripqHfw3faxx8SqfZb90gd3mKYjWD?=
 =?us-ascii?Q?6i4WUH6uqh8TmRBGYY3INWi2b8zNogajmcmwkR7ZnSPyiy00sKeuWNWmkPN3?=
 =?us-ascii?Q?t+xzshthYOkd4lI29zSGJrwkiNMvF4pn8LrxfTNILKc+24FhyYePpfXVBffg?=
 =?us-ascii?Q?1VS6ynak8uRCdg7xjryRLHVczscFRZt9jChwtNlWBDADdA55+a1vNTCmbwJe?=
 =?us-ascii?Q?fIz/0omdofiU77XPLbzEyl/ZSmHHMs3bDG4e2yKf46l7fZrz1hxdOaxeG1kF?=
 =?us-ascii?Q?WPDLJWXPuitsSrJfOc+nK8U0Pk3MxX22oLLN7OYG0CAskvXKVTjOrwlvSHBF?=
 =?us-ascii?Q?y7hQQQCSAjomBeY1nZSP82XTt/KLDWKF3+pCRMJTh1+fxD1AVi0qWOWttO8t?=
 =?us-ascii?Q?cO5d2JlD+Eldqa2niwz79T/ZNVCmPXZuxOkkc67OeHyAXTXdz3sDtqJHps6G?=
 =?us-ascii?Q?IY2puKT20sM894bK63hPwkJg4xrqCsFs2u0LrWmX2a5RiIA1G1m9zLaOQQ3D?=
 =?us-ascii?Q?7Q5buvxc74jFbCZ2YqXfonfFRYKWk+gM3FR+oWerErN4XJle/VIc83olxPIv?=
 =?us-ascii?Q?ev+ZP3Y8XG5RzSIzE4GxlDQhJNxk6g7ti0LZze/CmxPp95Yxz8hs4kfrOt7o?=
 =?us-ascii?Q?EL4YSb5iEkpX4CGxqANvqwGHwlqDhMqo5UawG
	d9CAF1OPVwXOsh+2QmWZ/bY?=
 =?us-ascii?Q?UXyFWGu72lSpVm8AW+8aSclPNumgykPaGaJeeJmAhRY2DdgsGzjQ9SilrI7E?=
 =?us-ascii?Q?stKZIQXq+YwgytOheJnZsGfEVm62b/dpz/sOg3iltPnPFNcjsaq/hXQJ3fOd?=
 =?us-ascii?Q?9f70QHy77ra2ej0Wr7IFvwL71SWt6Y05o0J/ZFSiPNGY5mlg/vpsQubbu8HL?=
 =?us-ascii?Q?PLqh2J9Sq0WxTfMG5PlxfZBraiAYTPZxJQdzSW9e+aPrWucQ/gFFW4fF1Ij1?=
 =?us-ascii?Q?TZ2gj6b8HZvGj/Zxpij9ERp/WA9NC1GfBVbRnQh7tb1AmeHSgkmozgT8xnLD?=
 =?us-ascii?Q?crPgHQ79iZsJ7isjNIfamrjapFs396ZmogoZnbJcBV1wjqdsgsIkF22yb9kR?=
 =?us-ascii?Q?JCxTBVZkyWyMKQOIvd4WvAyaTDXQqTgYiWLsARY143V3307mJDOFKMZjFrA6?=
 =?us-ascii?Q?MPZnDEvG+W+IUJfoyn9IW8cQBeKL7eZR9zIUFI06MJBmtsD9ut8Lo6scskyq?=
 =?us-ascii?Q?sclaCKL/fqPFCq4hO1oboSM5/RMOrCRiGfJ7kD/01iSORMDtyGWh35jfTxT4?=
 =?us-ascii?Q?usF1DGD19ooHJgaCkHGhDOdsMa5q6qbPJ8oZgI31NPuIMWeIiknDCcRQmlgL?=
 =?us-ascii?Q?3mGofSM4K6AZRDaqWYOfLJvPZiCPbdHnlBTIq6u21CARQvCE+uByWBY0MXui?=
 =?us-ascii?Q?7PhBAq3i2eNcIV3zcYBaoWHS87FSij9JHKiHTKqJ8+bH7v2pO7vl4rEusm5/?=
 =?us-ascii?Q?YBA1EJSWfZoyrwkY1R10s4B
	B5zAou/ZdEyDXedXqnICYAMNTSw7jgqqURFAi?=
 =?us-ascii?Q?Z6XN0o6R5CJelW+eKFX7ee+azuYbzS4yeoiTrHG4WYiLRicQEoENu3mclyAu?=
 =?us-ascii?Q?FWNOn82eF8xnVjvIxiXG0KlTrcLKJ03Q3k/b6rDqB1r8Xbu73JyBPXCdHRuu?=
 =?us-ascii?Q?TLp6Q47g01QFEviGh2GMXHbHkfDd/p12bayfw8Ms18mKF/jI7aSvOoV1xDYO?=
 =?us-ascii?Q?qIHCTLn9L1MmYn9fSvQAQdgoVCti2KmJZ8slW2DXFfy2xtcbcJmRm1reaZ44?=
 =?us-ascii?Q?tkn0lFu5XFLyQyE8hyLDhety7VBVr/CiSgUsZHEUKGXnrDUpQOGp4YND5Wxt?=
 =?us-ascii?Q?wemoA1HOn8K0CseQgIVwkvjC8s+DGBM3Lj5WPbwQD9LcAwMFC3v0Acc7j7j5?=
 =?us-ascii?Q?5fvvOONSJpnsY/AiyB/Q8TESn9HujnCMpG8U0VIqmzYtx3XOPvwTK9gDFv3B?=
 =?us-ascii?Q?q3pUyRXZGIjR/x0Uv1OyOHcN/Siqc4rvUU/0w/J8vsB50KiJyOAX88YebWm2?=
 =?us-ascii?Q?0TLR/DpZunmPLPfG5Z04D0p83Us0bSGnPC10J9DYgkXBHefHEgr8Wdi6XhHi?=
 =?us-ascii?Q?ddQ7qISUMXBukLOl00LBfddT0lsT7tAvITXKw4uZccjm6GcJYEHLbPl6wqtQ?=
 =?us-ascii?Q?VjNd+oC5gQ2aFXJ6h6F9BV+JVWlXv3c+Jttm4lkEKQcuhneciJEbmyrOYswt?=
 =?us-ascii?Q?g15zTfsZ2uqUafzPtoVG623LojnGgNAvii7xsQLHhriHerYZSjw6nRs3E8aJ?=
 =?us-ascii?Q?OSVn7EGpx
	RY7kEEVOHmCf6g746L9rT7jIWF3Vg5YjOVE/oAlY/W2QxBrEyRI?=
 =?us-ascii?Q?zvdCNBfclEi64A7o3/9j5rprmjZo6DYCq8H2f6ddjnBLO+OiSXxM9JhoqNII?=
 =?us-ascii?Q?p/rbi/2saG37IX9SFzzNLnRKKwDeia/fi3xSdPlFxFxbo8OCC01pOsWZKERC?=
 =?us-ascii?Q?MGOH0yBhu25CkK2W0ZmwMnDz?=
Content-Language: en-us
x-ms-exchange-organization-originalclientipaddress: 213.184.53.4
x-ms-exchange-organization-originalserveripaddress: 10.167.8.132
received-spf: None (mail1.rit.ee: no sender authenticity  information available from domain of  postmaster@spamgwp8.kliinikum.ee) identity=helo;  client-ip=185.50.98.202; receiver=mail1.rit.ee;  envelope-from="Taavi.Teder@kliinikum.ee";  x-sender="postmaster@spamgwp8.kliinikum.ee";  x-conformance=spf_only
dkim-signature: v=1; a=rsa-sha256; c=simple/simple;  d=kliinikum.ee; s=securemail; t=1781781535;  h=from:to:subject:date:message-id:   content-transfer-encoding:mime-version;  bh=99O7ImjrbazAaVKFOxlBmdPVlEf7Dh+Wpg0KDX1/88Q=;  b=QuooA5MNro9wNizigOgMEOV//kDrIYu+1pY2vc56qzqcDOTvtviIZqXG   w6G5v0FfwHtdc6XWuQDYHjSBM0WDIi5zUSw9gL8IMfDxZfTTKL/U6Ynqn   fKIOGr71gBQVI/o9wunOp8ZO+tPIyEUeLDjGTuLbsGZ8HZ6NfeNHKeLd8   A=;
X-OlkEid: 00000000D07AAE8E23CDBE4CA04D01CCD82FCB7E070034AD76187591974DBF6C4F76951C873A01000200000000005797C783AAECB34FA6C879FF487E64D9000000000D8F0000090A7D7C5E48404888D8D1DD13724D56
X-DisclaimerOO: 1
X-MS-Has-Attach: 
X-MS-TNEF-Correlator: 
acceptlanguage: en-US, et-EE
X-IPAS-Result: =?us-ascii?q?A0F+BgAp0zNqe8piMrlaHgE8DAILgWeCP4FoNAQLSR0BA?=
 =?us-ascii?q?ZZBmCyGIoE2BA8BAQEBAQELAU4BAgQBAQMBA5JGAh4HATgTAQIBAgEDAgMBA?=
 =?us-ascii?q?QEBAQEBAQEBAQsBAQEEAQEBAgEBAgQDAQEBAQIQAQFCSYZPAQxJARABggA7g?=
 =?us-ascii?q?hYsgVEBAREnEQEFeicEG4UdAk8HtX2BNIEBggwBAQYEAwICgl7ZRoFpCYFNh?=
 =?us-ascii?q?QVsgmoBhi6EeoFVRIQGC4t1giaBDINqjTcsgR4cA1ksAQ9GExcLBwWBZgMqL?=
 =?us-ascii?q?y1uMh2BIz4XCCxYGwcFgR6Be4EChQMjHwM5f4FogSVnZhUwNYECER8KgRsDC?=
 =?us-ascii?q?wdmPTcUGwQCAYE1jHAXD6stoUc0B4QggWYMgwGccC4XqmyZCCOodAIEAgQFA?=
 =?us-ascii?q?hg2gUkjgVwzGoNaUAMXAg+TD8UERzI9AQEHAgcOAwuBaIN3CIltgkguAYEcA?=
 =?us-ascii?q?QE?=
X-IronPort-Anti-Spam-Filtered: true
X-Amp-Result: SKIPPED(no attachment in message)
X-Amp-File-Uploaded: False
x-originating-ip: [193.40.49.26]

Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga.
Tundmatu saatja korral palume linke ja faile mitte avada.

Tere,


Olen Taavi Teder, anestesioloog/intensiivraviarst, Valga haigla ravijuht.


Küsin tervisejuhi töölaua osas konkreetselt raviskeemi kohta. Kahjuks ei
oska ise kuskile täpsemalt kirjutada niiet tuleb üldmeilile. Millised on
praegu ametlikud soovitused perearstidele mis puudutab raviskeemi ja selle
ajakohastamist? Sama küsimus siis haigla vaatest: kui patsient läheb koju,
siis kas ma saan oma osakonna arstidele ikkagi panna kohustuse see
raviskeem ka tervisejuhi töölaua vaatest üle vaadata/ära kinnitada või
millal tuleb selles osas mingit riikliku sisendit? Või see sisend on juba
antud ? Mina lihtsalt võibolla rumal ja ei tea.


Soome süsteemis töötanuna oli kohustus raviskeemi kontrollida/ajakohastada
perearstil vähemalt korra aastas. Samamoodi oli kohustus haiglaravi
lõppedes osakonna arstil see skeem üle vaadata, ajakohastada ja vajalikud
retseptid uuendada. Minu küsimus ravijuhi vaatest ongi siis see, et
milline on meie plaan või kehtiv süsteem. Või kui veel pole siis mida ma
ikkagi päriselus arstidele hetkel soovitan.


Lugupidamisega,

Taavi Teder
